ReviewJournal of hematology & oncology2022

Clinical experiences with venetoclax and other pro-apoptotic agents in lymphoid malignancies: lessons from monotherapy and chemotherapy combination.

Thomas E Lew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.